MedPath

Caregiver Burden and Correlation With Clinical Outcome in Spinal Cord Stimulation for Chronic Neuropathic Pain

Active, not recruiting
Conditions
Pain, Chronic
Pain, Neuropathic
Failed Back Surgery Syndrome
Registration Number
NCT04737746
Lead Sponsor
AZ Delta
Brief Summary

Prospective multicentric observational trial on caregiver burden, caregiver satisfaction and clinical outcome in spinal cord stimulation for chronic neuropathic pain.

Detailed Description

Spinal cord stimulation is an effective therapy for chronic neuropathic pain. After careful selection, the satisfaction for the patient is often considerable. The investigators want to investigate the caregiver burden for relatives of patients who are treated with spinal cord stimulation. This will be evaluated by appropriate scores at baseline, during neurostimulator trial and 3,6 and 12 months after implantation. At the same time the patient satisfaction and pain reduction will also be evaluated independently.

In this prospective cohort different parameters will be assessed at baseline, trial, 3, 6 and 12 months follow-up for the patient and their caregiver.

For the patient this will include Numeric Rating scale (NRS) for leg and back pain, Oswestry Disability Index (ODI), EuroQuality of Life-5 Dimensions score (EQ5D), opiate use and Relation Quality Index (RQI).

For the caregiver the Zarit Burden Index (ZBI), Relation Quality Index (RQI) and Modified Caregiver Strain Index (MCSI).

With regard to the research questions, subgroup analysis will be performed regarding to age, sex, education, neurostimulation pattern, surgical vs percutaneous lead placement, working status of both patient and caregiver and caregiver relation characteristics.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
42
Inclusion Criteria
  • Patients Age > 18 years
  • Patients with an identified spousal or offspring caregiver
  • Patients receiving neurostimulator for the first time
  • Patient complies to reimbursement criteria for spinal cord stimulation in Belgium
Exclusion Criteria
  • Non-spinal cord type of neuromodulation (DRG, occipital, peripheral nerve, )
  • Revision cases, previous neuromodulation
  • Patients unable to consent for this study
  • Patients without identified spousal or offspring caregiver

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
caregiver strain indexbaseline to 12 months
Zarit Burden indexbaseline to 12 months

Zarit Burden index measures the burden of a caregiver in 12 questions

relation quality index caregiverbaseline to 12 months
Secondary Outcome Measures
NameTimeMethod
NRS pain leg and backbaseline to 12 months

numeric rating scale

Oswestry Disability Indexbaseline to 12 months
EuroQol five dimensions EQ-5Dbaseline to 12 months
relation quality index patientbaseline to 12 months
analgetics dosebaseline to 12 months

analgetics ( paracetamol, opiates, opioids, non steroidal anti inflammatory and anti neuropathic pain medication

Trial Locations

Locations (2)

Jan Ypermanziekenhuis

🇧🇪

Ieper, Belgium

AZ Delta

🇧🇪

Roeselare, Belgium

© Copyright 2025. All Rights Reserved by MedPath